ARCHIVES

IDMC Halts Mekinist-Tafinlar Trial Early Due to OS Benefit; Recommends Crossover

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Coalition On Smoking Or Health to Launch Effort at $5 Tax Increase

July 3, 1992

Drugs and Targets: Akynzeo approved for chemotherapy-related nausea

October 10, 2014

CCOP Budget Needs Hefty Increase To Fund 55 Awards At Requested Levels, Yates Says

January 30, 1987

In Brief: Univ. of Texas Panel Selects Four finalists for M.D. Anderson Cancer Center Presidency

April 19, 1996

Prime Contract Subcontract Opportunities

January 24, 1975

In Brief: Bristol Has Change Of Heart, Agrees To Supply NCI With VP-16 Free For Group C Distribution

July 16, 1982